SCHEDULE 13G

Company

Eton Pharmaceuticals, Inc.

Filed

November 21, 2018

Accession Number

0000899140-18-000602

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →